A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

99mTc-labeled rHuEpo for imaging of the erythropoietin receptor in tumors




TekijätZhuang XQ, Zhao D, Yang PF, Jia YQ, Liang R, Zhao Q, Han CL, Kinsella JM, Sheng RL, Li J

KustantajaWILEY

Julkaisuvuosi2018

JournalJournal of Labelled Compounds and Radiopharmaceuticals

Tietokannassa oleva lehden nimiJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Lehden akronyymiJ LABELLED COMPD RAD

Vuosikerta61

Numero2

Aloitussivu77

Lopetussivu83

Sivujen määrä7

ISSN0362-4803

eISSN1099-1344

DOIhttps://doi.org/10.1002/jlcr.3586


Tiivistelmä
To analyze erythropoietin receptor (EpoR) status in tumors, recombinant human erythropoietin (rHuEpo) was labeled with Tc-99m by Tc-99m-centered 1-pot synthesis, resulting in high radiochemical purity, stability, and biological activity. Both in vitro cell culture experiments and biodistribution studies of normal rats demonstrated successful EpoR targeting. The biodistribution of labeled rHuEpo in a NCI-H1975 xenograft model showed tumor accumulation (tumor-to-muscle ratio, 4.27 +/- 1.77), confirming the expression of active EpoR in tumors. Thus, as a novel single positron emission computerized tomography tracer for the imaging of EpoR expression in vivo, Tc-99m-rHuEpo is effective for exploring the role of EpoR in cancer growth, metastasis and angiogenesis.



Last updated on 2024-26-11 at 21:03